Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6707
Source ID: NCT03660293
Associated Drug: Atorvastatin
Title: Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 1
Interventions: DRUG: Atorvastatin|DRUG: Captopril|DRUG: L-carnitine
Outcome Measures: Primary: The cardiac changes induced by Simvastatin, captopril and L-Carnitine in type 1 diabetic children and adolescents., Corrected QT interval(QTc) and QT dispersion in ElectroCardioGram, before and after 4 months of receiving cardio-protective agents|The cardiac changes induced by Simvastatin, captopril and L-Carnitine in type 1 diabetic children and adolescents., Left Ventricular End Systolic Volume (ml). Left Ventricular End Diastolic Volume (ml). Ejection Fraction (EF %) and left ventricular strain using echocardiography., before and after 4 months of receiving cardio-protective agents | Secondary: The role of Troponin I levels as a cardiac marker for detection of asymptomatic cardiovascular insult in diabetic children., Serum Cardiac troponin I by Enzyme Linked ImmunoSorbant Assay, first day|The role of recent echocardiographic parameters for early detection of silent myocardial dysfunction, Echocardiography, first day|Identification of risk factors for developing diabetic cardiac insult., first day
Sponsor/Collaborators: Sponsor: Tanta University
Gender: ALL
Age: CHILD, ADULT
Phases:
Enrollment: 150
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Start Date: 2017-04-01
Completion Date: 2019-06-01
Results First Posted:
Last Update Posted: 2019-06-17
Locations: Faculty of Medicine- Tanta University, Tanta, Gharbia, 0000, Egypt
URL: https://clinicaltrials.gov/show/NCT03660293